You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
29 January 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) announced on Thursday that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for ivonescimab in combination with c...
29 January 2026 - Spanish pharmaceutical company Almirall, S.A. (BME:ALM) announced on Thursday that China's National Medical Products Administration (NMPA) has approved Seysara (sarecycline hydrochloride) for the treatment of inflammatory lesio...
29 January 2026 - Global biotechnology company Alvotech S.A. (NASDAQ:ALVO) announced on Thursday that it has entered into a licensing and settlement agreement with US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) and German pharma...
29 January 2026 - French biotechnology company OSE Immunotherapeutics SA (Euronext Paris:OSE) said on Thursday that it has selected chronic pouchitis and hidradenitis suppurativa as new key clinical indications for its IL-7R antagonist lusvertikimab ...
29 January 2026 - Quantitative Systems Pharmacology (QSP) modelling specialist InSysBio announced on Wednesday an extension of its collaboration with oncology company BeOne Medicines.In this project, mechanistic translational modelling will be applie...
29 January 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Wednesday that it has formed a collaboration with biomedical innovation company Sinorda Biomedicine ...
28 January 2026 - Biotechnology company Biogen Inc (Nasdaq:BIIB) announced on Wednesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for litifilimab (BIIB059) to treat cutaneous lupus erythematosus (CLE)...